DK136251B - Analogifremgangsmåde til fremstilling af 1-acyleret kanamycin A eller B. - Google Patents

Analogifremgangsmåde til fremstilling af 1-acyleret kanamycin A eller B.

Info

Publication number
DK136251B
DK136251B DK346172AA DK346172A DK136251B DK 136251 B DK136251 B DK 136251B DK 346172A A DK346172A A DK 346172AA DK 346172 A DK346172 A DK 346172A DK 136251 B DK136251 B DK 136251B
Authority
DK
Denmark
Prior art keywords
preparation
analogous process
acylated kanamycin
kanamycin
acylated
Prior art date
Application number
DK346172AA
Other languages
English (en)
Other versions
DK136251C (da
Inventor
Hiroshi Kawaguchi
Takayuki Naito
Susumu Nakagawa
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to DK23675A priority Critical patent/DK138334B/da
Publication of DK136251B publication Critical patent/DK136251B/da
Application granted granted Critical
Publication of DK136251C publication Critical patent/DK136251C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK346172AA 1971-07-13 1972-07-11 Analogifremgangsmåde til fremstilling af 1-acyleret kanamycin A eller B. DK136251B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK23675A DK138334B (da) 1971-07-13 1975-01-24 Kanamycinderivater til anvendelse som mellemprodukter ved fremstillingen af antibakterielle derivater af kanamycin A eller B eller syreadditionssalte deraf.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16231571A 1971-07-13 1971-07-13
US22137872A 1972-01-27 1972-01-27

Publications (2)

Publication Number Publication Date
DK136251B true DK136251B (da) 1977-09-12
DK136251C DK136251C (da) 1978-02-13

Family

ID=26858650

Family Applications (1)

Application Number Title Priority Date Filing Date
DK346172AA DK136251B (da) 1971-07-13 1972-07-11 Analogifremgangsmåde til fremstilling af 1-acyleret kanamycin A eller B.

Country Status (24)

Country Link
JP (1) JPS5239024B2 (da)
AR (1) AR201265A1 (da)
AU (1) AU462657B2 (da)
BE (1) BE786201A (da)
CA (1) CA966831A (da)
CH (1) CH577502A5 (da)
CY (1) CY953A (da)
DD (1) DD98927A5 (da)
DK (1) DK136251B (da)
EG (1) EG10889A (da)
ES (1) ES404747A1 (da)
FI (1) FI56388C (da)
FR (1) FR2145649B1 (da)
GB (1) GB1401221A (da)
HK (1) HK33678A (da)
IE (1) IE36539B1 (da)
IL (1) IL39872A (da)
KE (1) KE2850A (da)
MY (1) MY7800312A (da)
NL (1) NL160271C (da)
PH (2) PH9589A (da)
SE (1) SE392470B (da)
SG (1) SG20778G (da)
YU (1) YU36533B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154536A (en) * 1974-11-06 1976-05-13 Banyu Pharma Co Ltd 6**nn * benjiruokishikaruboniru * kanamaishinjudotaino seiho
FR2318648A1 (fr) * 1975-07-23 1977-02-18 Roussel Uclaf Nouveau derive de la desoxystreptamine et des sels, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
IE36539B1 (en) 1976-11-24
DD98927A5 (da) 1973-07-12
DE2234315A1 (de) 1973-02-08
AU4434372A (en) 1974-01-10
JPS4834856A (da) 1973-05-22
PH11440A (en) 1978-02-01
BE786201A (fr) 1973-01-12
CY953A (en) 1978-12-22
SG20778G (en) 1987-04-03
IL39872A (en) 1974-10-22
NL7209617A (da) 1973-01-16
YU36533B (en) 1984-02-29
MY7800312A (en) 1978-12-31
IL39872A0 (en) 1972-09-28
CA966831A (en) 1975-04-29
AU462657B2 (en) 1975-07-03
ES404747A1 (es) 1976-04-16
PH9589A (en) 1976-01-19
EG10889A (en) 1976-10-31
FI56388B (fi) 1979-09-28
JPS5239024B2 (da) 1977-10-03
YU181872A (en) 1982-02-25
SE392470B (sv) 1977-03-28
GB1401221A (en) 1975-07-16
IE36539L (en) 1973-01-13
HK33678A (en) 1978-07-07
FR2145649B1 (da) 1976-04-16
FI56388C (fi) 1980-01-10
NL160271C (nl) 1979-10-15
AR201265A1 (es) 1975-02-28
FR2145649A1 (da) 1973-02-23
CH577502A5 (da) 1976-07-15
DK136251C (da) 1978-02-13
KE2850A (en) 1978-08-04
DE2234315B2 (de) 1977-03-17
NL160271B (nl) 1979-05-15

Similar Documents

Publication Publication Date Title
DK138419B (da) Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol.
DK133986B (da) Analogifremgangsmåde til fremstilling af 5-(1-oxo-5-indanyloxy)-tetrazoler eller 5-(1-oxo-5-indanyloxymethyl)-tetrazoler.
DK134316B (da) Fremgangsmåde til fremstilling af methylsubstituerede cuinoner.
DK139720B (da) Analogifremgangsmåde til fremstilling af pleuromutiliner.
DK131760B (da) Fremgangsmåde til fremstilling af et insulinsalt-protaminkomplex.
DK133828B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK129987B (da) Analogifremgangsmåde til fremstilling af guanidiner.
DK135799B (da) Fremgangsmåde til fremstilling af ethambutol.
DK127119B (da) Analogifremgangsmåde til fremstilling af 6-amino-9-benzylpurin-forbindelser.
DK129573B (da) Analogifremgangsmåde til fremstilling af 4-(4-biphenylyl)-1-butanol.
DK140596B (da) Analogifremgangsmåde til fremstilling af 8beta-(ureidomethyl)-ergolenderivater.
DK130212B (da) Analogifremgangsmåde til fremstilling af 7-aminoindazolderivater.
DK133470B (da) Fremgangsmåde til fremstilling af 3alfa-hydroxy-5alfa-steroider.
DK138229B (da) Fremgangsmåde til fremstilling af (+)(-)-eburnamonin.
DK130959B (da) Analogifremgangsmåde til fremstilling af benzamidoacetohydroxamsyrer.
DK132221B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK133464B (da) Analogifremgangsmåde til fremstilling af nitrosourinstofderivater.
DK131296B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-19-nor-5alfa-pregnan-11,20-dion.
DK130745B (da) Fremgangsmåde til fremstilling af transparente copolyamider.
DK129794B (da) Analogifremgangsmåde til fremstilling af N-acyl-3-(piperazinoethyl)-pyrazoler.
DK126780B (da) Fremgangsmåde til fremstilling af flavon-7-oxyacetater.
DK136251B (da) Analogifremgangsmåde til fremstilling af 1-acyleret kanamycin A eller B.
DK130987B (da) Analogifremgangsmåde til fremstilling af 15alfa,16alfa-methylen-4-androsten-3-oner.
DK140896B (da) Fremgangsmåde til fremstilling af en 7-D-alfa-aminoacetamidocephalosporin-4-carboxylsyre.
DK128736B (da) Analogifremgangsmåde til fremstilling af 3,17β-dialkoxy-estra-1,3,5(10)-triener.

Legal Events

Date Code Title Description
PUP Patent expired